Medscape1d
Drug-Drug Interactions With Glucagon-like Peptide-1 Receptor Agonists
Objective: To review drug interaction studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs ... to further assess and allow comparison of several GLP-1RA agents' impact on steady-state ...
JD Supra12d
GLP-1 Receptor Agonists and Patent Strategy: Securing Patent Protection for New Use of Old Drugs
GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...
Medical Xpress16d
Risk for specific hematologic cancers down with GLP-1 receptor agonist use in type 2 diabetes
For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA ... a retrospective cohort study to compare the risks for hematologic cancers in patients with T2D treated ...
Pulmonology Advisor19h
No Link Seen Between Preop GLP-1 Receptor Agonist Use and Postop Aspiration Pneumonia
HealthDay News — Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not associated with short-term postoperative aspiration pneumonia, according to a study published online March ...
Structure: A Lot Riding On Next Data Readout For Oral GLP-1 Candidate
Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...
Physician's Weekly5d
GLP-1 Receptor Agonists and Hematologic Cancer Risk in Type 2 Diabetes
The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...
Monthly Prescribing Reference14d
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist ... to compare the risks for hematologic cancers in patients with T2D treated with a GLP ...